Table S1. X-ray data collection and refinement statistics

Similar documents
Supplementary Table 1. Data collection and refinement statistics (molecular replacement).

Supporting Information

SUPPLEMENTARY INFORMATION

FCC2 5CY7 FCC1 5CY8. Actinonin 5CVQ

172R 172K TAM-2/172R TAM-2/172K. AZT concentration [nm] AZT concentration [nm] MgCl 2 2.5K 2.5K 5K 2.5K 5K 2.5K K 5K 2.5K 5K 2.5K 50 2.

Supplementary Information Janssen et al.

SUPPLEMENTARY INFORMATION

Atypical Natural Killer T-cell receptor recognition of CD1d-lipid antigens supplementary Information.

(B D) Three views of the final refined 2Fo-Fc electron density map of the Vpr (red)-ung2 (green) interacting region, contoured at 1.4σ.

Supporting Information

Supplementary Figure 1. Heavy chain sequences of 2G1 and 8M2 aligned with V H 1-69

Detergent solubilised 5 TMD binds pregnanolone at the Q245 neurosteroid potentiation site.

Chapter 6. X-ray structure analysis of D30N tethered HIV-1 protease. dimer/saquinavir complex

Supplementary Figure 1 (previous page). EM analysis of full-length GCGR. (a) Exemplary tilt pair images of the GCGR mab23 complex acquired for Random

SUPPLEMENTARY INFORMATION. Computational Assay of H7N9 Influenza Neuraminidase Reveals R292K Mutation Reduces Drug Binding Affinity

SUPPLEMENTARY INFORMATION

Supplementary Materials for

SUPPLEMENTARY INFORMATION FOR. (R)-Profens Are Substrate-Selective Inhibitors of Endocannabinoid Oxygenation. by COX-2

Transient β-hairpin Formation in α-synuclein Monomer Revealed by Coarse-grained Molecular Dynamics Simulation

Supporting Information

Supplementary Materials for

SUPPLEMENTAL MATERIAL. UNC119 is required for G protein trafficking in sensory neurons

Supplemental Information. An Atlas of b-glucuronidases. in the Human Intestinal Microbiome

Structure of the measles virus hemagglutinin bound to the CD46 receptor. César Santiago, María L. Celma, Thilo Stehle and José M.

Supplementary Figure 1 Overall structure of the transmembrane pore of FraC. a, Crystal packing of the pore along the y-z, b, the z-x, and c, the y-x

Figure S1. HP1α localizes to centromeres in mitosis and interacts with INCENP. (A&B) HeLa

SUPPLEMENTARY INFORMATION (SI) FIGURES AND TABLES

Supplementary Figure 1 Preparation, crystallization and structure determination of EpEX. (a), Purified EpEX and EpEX analyzed on homogenous 12.

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1

Table S1: Kinetic parameters of drug and substrate binding to wild type and HIV-1 protease variants. Data adapted from Ref. 6 in main text.

List of Figures. List of Tables

Supplementary Materials for

An esterase from anaerobic Clostridium hathewayi can hydrolyze aliphatic-aromatic polyesters

Nature Immunology: doi: /ni Supplementary Figure 1. Infection strategy.

Supplementary Information for Structural basis for the inhibition of Polo-like kinase 1

Supplementary Material

Supplementary Information

KDM2A. Reactions. containing. Reactions

Constructs expressing recombinant proteins were generated by PCR; mutant variants were

Supplementary Figure S1. Supplementary Figure S1. Chemical structure of CH

Supplementary Information

SUPPORTING INFORMATION FOR. A Computational Approach to Enzyme Design: Using Docking and MM- GBSA Scoring

Data collection. Refinement. R[F 2 >2(F 2 )] = wr(f 2 ) = S = reflections 326 parameters 2 restraints

Nature Structural & Molecular Biology: doi: /nsmb.1933

obtained for the simulations of the E2 conformation of SERCA in a pure POPC lipid bilayer (blue) and in a

SUPPLEMENTARY INFORMATION

The Binding Mode of by Electron Crystallography

Supporting Information

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen

The mechanism of patellamide macrocyclization revealed by study of the Prochloron sp PatG macrocyclase domain

HOMEWORK II and Swiss-PDB Viewer Tutorial DUE 9/26/03 62 points total. The ph at which a peptide has no net charge is its isoelectric point.

data reports Bis[S-hexyl 3-(thiophen-2-ylmethylidene)dithiocarbazato-j 2 N 3,S]palladium(II) Structure description

SUPPLEMENTARY INFORMATION

Experimental. Crystal data. C 22 H 26 N 2 O 3 M r = Triclinic, P1 a = (3) Å b = (4) Å c = (4) Å = (6) = 100.

Rene Peschar Jan B. van Mechelen, Henk Schenk

ATP-independent reversal of a membrane protein aggregate by a chloroplast SRP

Insights into the Giardia intestinalis Enolase and Human Plasminogen interaction

Biochemical and Biophysical Research Communications 346 (2006) Crystal structure of rat carnitine palmitoyltransferase II (CPT-II)

Robyn L Malby', William R Tulip 2 t, Vincent R Harley 2 *, Jennifer L McKimm-Breschkin, W Graeme Laver 3, Robert G Webster 4 and Peter M Colman 1 *

metal-organic compounds

Supplementary information: Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors

Nature Structural and Molecular Biology: doi: /nsmb Supplementary Figure 1

Characterizing the mesophase behavior of hydrated 9.9 MAG at 20 C and at increasing concentrations of DDM by SAXS.

Amino Acids. Review I: Protein Structure. Amino Acids: Structures. Amino Acids (contd.) Rajan Munshi

Experimental. Crystal data. C 19 H 19 N 3 O 3 M r = Monoclinic, C2=c a = (3) Å b = (2) Å c = (3) Å = 110.

In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

This PDF file includes: Supplementary Figures 1 to 6 Supplementary Tables 1 to 2 Supplementary Methods Supplementary References

Crystallization-grade After D After V3 cocktail. Time (s) Time (s) Time (s) Time (s) Time (s) Time (s)

Thermal shift binding experiments were carried out using Thermofluor 384 ELS system. Protein

The structural organization of substrate loading in iterative polyketide synthases

Supplementary Materials for

Rapid Characterization of Allosteric Networks. with Ensemble Normal Mode Analysis

Introduction to proteins and protein structure

Bioinformatics for molecular biology

The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism

metal-organic compounds

Cheiron School BL Practice of BL38B1 (Protein Crystallography)

Experimental. Crystal data. C 12 H 20 N 4 O M r = Orthorhombic, P a = (3) Å b = (4) Å c = 14.

organic compounds (E)-Ethyl N 0 -(3-hydroxybenzylidene)- hydrazinecarboxylate dihydrate

The Structure of Holo and Metal-deficient Wild-type Human Cu, Zn Superoxide Dismutase and its Relevance to Familial Amyotrophic Lateral Sclerosis

data reports cis-cyclohexane-1,3-dicarboxylic acid N,N 0 -(pentane-1,5-diyl)bis(pyridine-4-carboxamide) water (1/1/2) Structure description

Supplementary Information for. Heavy chain-only IgG2b-llama antibody effects near-pan HIV-1 neutralization by

Carmen Berthet-Colominas, Stéphanie Monaco, Armelle Novelli 1, Geneviève Sibaï 2, François Mallet 1 and Stephen Cusack 3.

TEMA 5. ANTICUERPOS Y SUS RECEPTORES

SDS-Assisted Protein Transport Through Solid-State Nanopores

Project Manual Bio3055. Cholesterol Homeostasis: HMG-CoA Reductase

Supplementary information. macrophages in foam cells

BMC Biology. Open Access. Abstract. BioMed Central

Structural basis for dual inhibitory role of tamarind Kunitz inhibitor (TKI) against factor Xa and trypsin

Final Report. Identification of Residue Mutations that Increase the Binding Affinity of LSTc to HA RBD. Wendy Fong ( 方美珍 ) CNIC; Beijing, China

Structural Analysis of TCRpMHC Complexes Using Computational Tools. Feroze Mohideen Briarcliff High School

STRUCTURE OF A UBIQUITIN-LOADED HECT LIGASE REVEALS THE MOLECULAR BASIS FOR CATALYTIC PRIMING SUPPLEMENTARY INFORMATION

Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters

Crystal Structure of the Subtilisin Carlsberg: OMTKY3 Complex

= (3) = (3) = (4) V = (4) Å 3 Z =2. Data collection. Refinement

Copyright Mark Brandt, Ph.D. 46

1. Arresting cancer by energy starvation

Full wwpdb NMR Structure Validation Report

Protein Refinement in Discovery Studio 1.7. Presented by: Francisco Hernandez-Guzman, PhD

Bioinformation Volume 5

Transcription:

Table S1. X-ray data collection and refinement statistics Data collection H7.167 Fab-Sh2/H7 complex Beamline SSRL 12-2 Wavelength (Å) 0.97950 Space group I2 1 3 Unit cell parameters (Å, º) a = b = c=207.3, α =β =γ = 90.0 Resolution (Å) 50 4.65 (4.73 4.65) a Unique reflections 8,097 (393) a R merge (%) b 7.6 (97.2) a R pim (%) b 1.9 (28.3) a I/sigma 46.7 (2.2) a Completeness (%) 100.0 (100.0) a Redundancy c Z a 18.4 (12.5) a 1 Refinement statistics Resolution 46.3 4.66 Reflections used in refinement 8,095 R cryst (%) d 32.6 R free (%) e 35.4 Protein atoms 5,599 Waters 0 Other 0 Average B-value (Å 2 ) Overall 194 Wilson 295 RMSD from ideal geometry Bond length (Å) 0.002 Bond angles ( ) 0.582 Ramachandran statistics (%) f Favored 90.1 Outliers 1.2 PDB ID 5F45 a Numbers in parenthesis refer to the highest resolution shell. b R merge = Σ hkl Σ i I hkl,i - <I hkl > / Σ hkl Σ i I hkl,i and R pim = Σ hkl [1/(n-1)] 1/2 Σ i I hkl,i - <I hkl > / Σ hkl Σ i I hkl,i, where I hkl,i is the scaled intensity of the i th measurement of reflection h, k, l, < I hkl > is the average intensity for that reflection, and n is the redundancy. c Z a is the number of HA monomer-fab complexes per crystallographic asymmetric unit. d R cryst = Σ F o - F c / Σ F o x 100, where F o and F c are the observed and calculated structure factors, respectively. e R free was calculated as for R cryst, but on a random test set comprising 5% of the data excluded from refinement. f Calculated using MolProbity (43). 1

Figure S1. Representative electron density at the H7.167 Fab-Sh2/H7 complex interface. The H7.167 variable heavy and light chains are colored magenta and yellow and the HA1 is colored green. The 2F o -F c electron density map (blue mesh) is contoured at 1σ. 2

Table S2. Conservation of H7.167 epitope residues in H7 HAs and comparison with representative HAs from H1, H2, H3 and H5 (H3 numbering). Subtype Isolate Contacting residues at position in HAs 131 157 158A 158B 159 160 161 197 200 248 H7N9 A/Shanghai/02/2013 R N D N A A F S K N H7N9 A/Shanghai/01/2013 R N D N A A F S K N H7N7 A/Netherlands/219/2003 R N D N A A F S K N H7N2 A/New York/107/2003 R N D N A A F S K N H1N1 A/Texas/36/1991 T K S S Y N D T H2N2 A/Japan/305/1957 T K S N Y N G T H3N2 A/Victoria/361/2011 T L F K Y Q S T H5N1 A/Vietnam/1203/2004 A K S T Y N T N No residue inserts at this position. 3

Figure S2. Sequence and structure comparison of the 150-loop from different HA subtypes. (A) Sequence alignment of the 150-loop in H7 HAs with those from H1/H2/H3/H5. The inserted residues 158A and 158B are labeled with red box. (B) Superposition of the 150-loop from H7N9 (A/Shanghai/02/2013) (green, PDB 4N5J), H1N1 (A/BrevigMission/1/1918) (cyan, PDB 3GBN), H2N2 (A/Singapore/1/1957) (wheat, PDB 4HFU), H3N2 (A/Victoria/261/2011) (blue, PDB 4O5N) and H5N1 (A/Vietnam/CL12/2004) (lavender, PDB 4BGX) HAs. The 158A and 158B side chains in H7 HA are shown in green sticks. The unique conformation of the 150-loop of H7 HA and insertion of 158A and 158B in this loop are likely associated with the particular specificity of this H7.167 HA. 4

Figure S3. Surface representation analysis of the escape mutants N157D and N158BD of Sh2/H7 HA to antibody H7.167. (A) Electrostatic potential surfaces (red, negative, 5.4 kt; blue, positive, +5.4 kt; white, neutral) around wild-type Sh2/H7 HA with N157 and N158B (green sticks). (B) Electrostatic potential surfaces around Sh2/H7 HA mutants model with N157D and N158BD (green sticks), in the same orientation as A. The N157D and N158BD mutations alter the electrostatic potential from near neutral (A) to weakly acidic (B) around HA1 position N157 and N158B, rendering it unfavorable for binding to H7.167, which is also weakly acidic around the paratope site of interaction with HA1 N157 and N158B (B). 5

Table S3. Primer sets used for RT-PCR amplification of antibody gene cdnas Name Heavy-chain primers Forward primers IgExp-A_5ʹL-VH1 IgExp-A_5ʹL-VH2 IgExp-A_5ʹL-VH3 IgExp-A_5ʹL-VH4 IgExp-A_5'L-VH5 IgExp-A_5ʹL-VH6 IgExp-A_5ʹL-VH7 Reverse primer IgExp-B_3ʹCH1 Light-chain primers Forward κ-chain primers IgExp-A_5ʹL-VK1 IgExp-A_5ʹL-VK2 IgExp-A_5ʹL-VK3 IgExp-A_5ʹL-VK4 IgExp-A_5ʹL-VK5 IgExp-A_5ʹL-VK6 Reverse κ-chain primer IgExp-B_3ʹCK1 Forward λ-chain primers IgExp-A_5ʹL-VL1 IgExp-A_5ʹL-VL2 IgExp-A_5ʹL-VL3 IgExp-A_5ʹL-VL4 IgExp-A_5ʹL-VL5 IgExp-A_5ʹL-VL6 IgExp-A_5ʹL-VL7 IgExp-A_5ʹL-VL8 IgExp-A_5ʹL-VL9 IgExp-A_5ʹL-VL10 IgExp-A_5ʹL-VL11 Reverse λ-chain primer IgExp-B_3ʹCL1 Primer Sequence (5ʹ 3ʹ) GTTTTAAAAGGTGTCCTGTGTCARRTNCAGCTGGTRCAGTC GTTTTAAAAGGTGTCCTGTGTCAGRTCACCTTGARGGAGTC GTTTTAAAAGGTGTCCTGTGTSARGTGCAGCTGGTGGAGTC GTTTTAAAAGGTGTCCTGTGTCAGSTGCAGCTRSAGGAGTC GTTTTAAAAGGTGTCCTGTGTGARGTGCAGCTGGTGCAGTC GTTTTAAAAGGTGTCCTGTGTCAGGTACAGCTGCAGCAGTC GTTTTAAAAGGTGTCCTGTGTCAGGTGCAGCTGGTGCAGTC GATGGGCCCTTGAAGCTTGCTGAGGAGACGGTGACCAGGGT GAATCCCAGGCATGAGATCTGMCATCCRGWTGACCCAG GAATCCCAGGCATGAGATCTGAKRTTGTGATGACYCAG GAATCCCAGGCATGAGATCTGAAATWGTRWTGACRCAG GAATCCCAGGCATGAGATCTGACATCGTGATGACCCAG GAATCCCAGGCATGAGATCTGAAACGACACTCACGCAG GAATCCCAGGCATGAGATCTGAWRTTGTGMTGACWCAG GATGGCGGGAAGATGAAGACAGATGGTGCGGCCGCAGT GAATCCCAGGCATGAGATCTCAGTCTGTSBTGACKCAG GAATCCCAGGCATGAGATCTCARTCTGCCCTGACTCAG GAATCCCAGGCATGAGATCTTCCTMTGDGCYRAYWCAG GAATCCCAGGCATGAGATCTCWGCYTGTGCTGACTCAA GAATCCCAGGCATGAGATCTCAGSCTGTGCTGACTCAG GAATCCCAGGCATGAGATCTAATTTTATGCTGACTCAG GAATCCCAGGCATGAGATCTCAGRCTGTGGTGACTCAG GAATCCCAGGCATGAGATCTCAGWCTGTGGTGACCCAG GAATCCCAGGCATGAGATCTCAGCCTGTGCTGACTCAG GAATCCCAGGCATGAGATCTCAGGCAGGGCTGACTCAG GAATCCCAGGCATGAGATCTCGGCCCGTGCTGACTCAG AGGGGGGAACAGAGTGACASTTGGAGCGGCCTTAGGCTG 6